Page last updated: 2024-08-21

ethambutol and clotrimazole

ethambutol has been researched along with clotrimazole in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chitra, S; Manisankar, P; Muthusubramanian, S; Paul, N; Sriram, D; Yogeeswari, P1
Anand, N; Chaturvedi, V; Dwivedi, AK; Gupt, MP; Gupta, V; Kumar, B; Lal, J; Pandey, S; Pandey, SK; Rai, N; Ramachandran, R; Ramakrishna, KK; Sharma, P; Shukla, PK; Singh, S; Srivastava, KK; Tripathi, RP1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1

Reviews

1 review(s) available for ethambutol and clotrimazole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for ethambutol and clotrimazole

ArticleYear
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries

2009
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:11

    Topics: Anti-Bacterial Agents; Azoles; Candida albicans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis

2011
Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents.
    ACS medicinal chemistry letters, 2013, Oct-10, Volume: 4, Issue:10

    Topics:

2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016